Klein, Teri - Stanford University - Department of Medicine

个人简介

B.A., UC Santa Cruz, Chemistry/Biology (1980) Ph.D., UC San Francisco, Medical Information Sciences (1987)

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Prediction of CYP2D6 phenotype from genotype across world populations. Genetics in medicineGaedigk, A., Sangkuhl, K., Whirl-Carrillo, M., Klein, T., Leeder, J. S.2016 Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans BLOODDaneshjou, R., Gamazon, E. R., Burkley, B., Cavallari, L. H., Johnson, J. A., Klein, T. E., Limdi, N., Hillenmeyer, S., Percha, B., Karczewski, K. J., Langaee, T., Patel, S. R., Bustamante, C. D., Altman, R. B., Perera, M. A.2014; 124 (14): 2298-2305 CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations CLINICAL PHARMACOLOGY & THERAPEUTICSProvince, M. A., Goetz, M. P., Brauch, H., Flockhare, D. A., Hebert, J. M., Whaley, R., Suman, V. J., Schroth, W., Winter, S., Zembutsu, H., Mushiroda, T., Newman, W. G., Lee, M. M., Ambrosone, C. B., Beckmann, M. W., Choi, J., Dieudonne, A., Fasching, P. A., Ferraldeschi, R., Gong, L., Haschke-Becher, E., Howel, A., Jordan, L. B., Hamann, U., Kiyotani, K., Krippl, P., Lambrechts, D., Latif, A., Langsenlehner, U., Lorizio, W., Neven, P., Nguyen, A. T., Park, B., Purdie, C. A., Quinlan, P., Renner, W., Schmidt, M., Schwab, M., Shin, J., Stingl, J. C., Wegman, P., Wingren, S., Wu, A. H., Ziv, E., ZIRPOLI, G., Thompson, A. M., Jordan, V. C., Nakamura, Y., Altman, R. B., Ames, M. M., Weinshilboum, R. M., Eichelbaum, M., Ingle, J. N., Klein, T. E.All Authors2014; 95 (2): 216-227 Clinical Implementation of Pharmacogenetics: More Than One Gene at a Time CLINICAL PHARMACOLOGY & THERAPEUTICSJohnson, J. A., Klein, T. E., RELLING, M. V.2013; 93 (5): 384-385 Pharmacogenomics Knowledge for Personalized Medicine CLINICAL PHARMACOLOGY & THERAPEUTICSWhirl-Carrillo, M., MCDONAGH, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., Klein, T. E.2012; 92 (4): 414-417 Clopidogrel: A Case for Indication-Specific Pharmacogenetics CLINICAL PHARMACOLOGY & THERAPEUTICSJohnson, J. A., Roden, D. M., Lesko, L. J., Ashley, E., Klein, T. E., Shuldiner, A. R.2012; 91 (5): 774-776 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype CLINICAL PHARMACOLOGY & THERAPEUTICSCrews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D. D., Callaghan, J. T., Kharasch, E. D., Skaar, T. C.2012; 91 (2): 321-326 CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network CLINICAL PHARMACOLOGY & THERAPEUTICSRelling, M. V., Klein, T. E.2011; 89 (3): 464-467 Clinical assessment incorporating a personal genome LANCETAshley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., Dudley, J. T., Ormond, K. E., Pavlovic, A., Morgan, A. A., Pushkarev, D., Neff, N. F., Hudgins, L., Gong, L., Hodges, L. M., Berlin, D. S., Thorn, C. F., Sangkuhl, K., Hebert, J. M., Woon, M., Sagreiya, H., Whaley, R., Knowles, J. W., Chou, M. F., Thakuria, J. V., Rosenbaum, A. M., Zaranek, A. W., Church, G. M., Greely, H. T., Quake, S. R., Altman, R. B.All Authors2010; 375 (9725): 1525-1535 Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans. Molecular genetics & genomic medicineDaneshjou, R., Cavallari, L. H., Weeke, P. E., Karczewski, K. J., Drozda, K., Perera, M. A., Johnson, J. A., Klein, T. E., Bustamante, C. D., Roden, D. M., Shaffer, C., Denny, J. C., Zehnder, J. L., Altman, R. B.2016; 4 (5): 513-520